Format

Send to

Choose Destination
Sci Rep. 2017 Sep 4;7(1):10382. doi: 10.1038/s41598-017-10863-4.

Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment.

Author information

1
Department of Biomedical Engineering, Boston University, Boston, MA, 02215, USA.
2
Department of Chemistry, Boston University, Boston, MA, 02215, USA.
3
Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, 02215, USA.
4
Department of Biomedical Engineering, Boston University, Boston, MA, 02215, USA. zaman@bu.edu.
5
Howard Hughes Medical Institute, Boston University, Boston, MA, 02118, USA. zaman@bu.edu.
6
Department of Biomedical Engineering, Boston University, Boston, MA, 02215, USA. mgrin@bu.edu.
7
Department of Chemistry, Boston University, Boston, MA, 02215, USA. mgrin@bu.edu.
8
Department of Medicine, Boston University School of Medicine, Boston, MA, 02118, USA. mgrin@bu.edu.

Abstract

An abnormal multicellular architecture is a defining characteristic of breast cancer and, yet, most in vitro tumor models fail to recapitulate this architecture or accurately predict in vivo cellular responses to therapeutics. The efficacy of two front-line chemotherapeutic agents (paclitaxel and cisplatin) are described within three distinct in vitro models employing the triple-negative basal breast cancer cell line MDA-MB-231 and the luminal breast cancer cell line MCF7: a) a 3D collagen embedded multicellular spheroid tumor model, which reflects the architecture and cellular heterogeneity of tumors in vivo; b) a 3D collagen model with a single cell-type diffusely embedded; and c) a 2D monolayer. The MDA-MB-231 embedded spheroid tumor model exhibited the most robust response to chemotherapeutic treatment, and possessed the greatest cancer stem cell (CSC) content. CSC-related genes are elevated across all MDA-MB-231 in vitro models following paclitaxel treatment, indicating that paclitaxel enrichment of chemoresistant CSCs is less dependent on microenvironmental tumor structure, while cisplatin showed a more context-dependent response. In the MCF7 cell models a context-dependent response is observed with paclitaxel treatment increasing the CSC related genes in the 2D monolayer and 3D diffuse models while cisplatin treatment afforded an increase in ALDH1A3 expression in all three models.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center